Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Assoc. Prof. Dr. Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Hawassa University College of Medicine and Health Sciences | Ethiopia

Dr. Alemayehu Toma is an Associate Professor of Pharmacology at Hawassa University, Ethiopia, and an accomplished researcher whose work bridges pharmacological science with public health impact. His professional career reflects an unwavering dedication to advancing medical knowledge, improving patient outcomes, and addressing pressing health challenges in both local and global contexts. Over his career, he has built an outstanding reputation for his research in HIV/AIDS treatment outcomes, pharmacovigilance, nutrition-related interventions, and the safety and efficacy of medicinal plants. With 45 peer-reviewed publications and more than 3,900 citations on Google Scholar, his research has significantly influenced both scientific literature and healthcare practice.

Professional Profile

Google Scholar

ORCID

Education

Dr. Toma’s academic path demonstrates a progressive commitment to mastery in pharmacology and medical science. He earned his Ph.D. in Pharmacology from Addis Ababa University, preceded by a Master’s degree in Pharmacology from the same institution, and a Bachelor of Pharmacy from Jimma University. To further enhance his educational contributions, he obtained a Higher Diploma in Pedagogy from Hawassa University, equipping him with the expertise to deliver effective teaching and mentorship in higher education. His academic background integrates deep pharmacological knowledge with practical clinical insight and refined pedagogical skill.

Experience

Dr. Toma’s professional career spans teaching, research, clinical service, and academic leadership. At Hawassa University, he held the role of Associate Professor of Pharmacology in the College of Medicine and Health Sciences, where he was also Head of the Quality Assurance Office. He played a pivotal role in maintaining academic standards, developing research capacity, and ensuring the quality of medical education. He has also served as an Assistant Professor of Pharmacology at Komar University of Science and Technology in Iraq, where he contributed to curriculum development and supervised postgraduate theses. His work as a licensed pharmacy specialist reflects his hands-on involvement in patient care, linking academic expertise with clinical practice.

Research Interest

Dr. Toma’s research interests are diverse but strongly interconnected, focusing on areas where pharmacological science directly impacts human health. His core areas include HIV/AIDS treatment outcomes and comorbidities, the effects of pharmacological interventions on organ systems, antidiabetic and antimicrobial activities of medicinal plants, nutritional status among vulnerable populations, and epidemiological studies of chronic and infectious diseases. He also contributes to multi-country global health collaborations, such as disease burden mapping, which inform policy and public health programs. His work is characterized by methodological rigor, translational relevance, and a commitment to addressing real-world medical challenges.

Awards and Recognition

Dr. Toma’s contributions to pharmacology and public health have been acknowledged in prestigious journals including The Lancet, BMJ Open, Scientific Reports, and BMC Infectious Diseases. His h-index of 19 is evidence of sustained research influence, while his work’s consistent citation by peers shows its enduring value. His collaborative publications with international research networks further underscore his role as a key contributor to global health science.

Publications

Title: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Journal: The Lancet Respiratory Medicine
Published on: 2020
Citation: 2126

Title: Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the …
Journal: The Lancet HIV
Published on: 2019
Citation: 560

Title: Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease …
Journal: The Lancet
Published on: 2020
Citation: 152

Title: Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves
Journal: BMC Complementary and Alternative Medicine
Published on: 2014
Citation: 123

Title: Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats
Journal: BMC Complementary and Alternative Medicine
Published on: 2015
Citation: 121

Title: Phytochemistry and pharmacological activities of Moringa oleifera
Journal: International Journal of Pharmacognosy
Published on: 2014
Citation: 94

Title: Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of …
Journal: Occupational and Environmental Medicine
Published on: 2020
Citation: 76

Title: Antimicrobial resistance profile of Staphylococcus aureus isolates isolated from ear discharges of patients at University of Hawassa comprehensive specialized …
Journal: BMC Pharmacology and Toxicology
Published on: 2017
Citation: 74

Conclusion

Dr. Alemayehu Toma’s career stands as a model of academic excellence, research productivity, and societal impact. His studies have provided crucial insights into the management of HIV/AIDS, nutrition in vulnerable groups, medicinal plant pharmacology, and the global burden of diseases. He has consistently demonstrated the ability to translate research findings into actionable recommendations for health systems, contributing to policy change and improved clinical outcomes. His leadership in academia, commitment to mentoring emerging scholars, and active collaboration in international research initiatives make him an outstanding candidate for the Best Researcher Award. This recognition would not only honor his past achievements but also encourage further contributions that can transform healthcare practice in resource-limited settings worldwide.

 

Mellar Davis | Pharmacology | Best Researcher Award

Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

  • Extensive Research and Publications 📚

    • Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
    • Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
    • Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.
  • Significant Impact in Palliative Medicine 🌿

    • Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
    • Developed guidelines and educational programs for pain and opioid management in cancer care.
    • Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).
  • Recognized Excellence in Teaching and Mentorship 🎓

    • Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
    • Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.
  • Leadership and Professional Influence 🌍

    • Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
    • Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publications📚

  1. Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics

    • Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
    • Publication Year: 2025
  2. Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

    • Authors: M.P. Davis
    • Publication Year: 2025
  3. Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study

    • Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
    • Publication Year: 2024
  4. Respiratory Depression Associated with Opioids: A Narrative Review

    • Authors: M.P. Davis, S.L. DiScala, A. Davis
    • Publication Year: 2024
  5. The Surprise Question: Not Ready for Prime Time

    • Authors: M.P. Davis
    • Publication Year: 2024
  6. Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024
  7. Understanding The Number Needed to Treat

    • Authors: M.P. Davis, E.A. Vanenkevort
    • Publication Year: 2024
  8. Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024
  9. Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia

    • Authors: M.P. Davis
    • Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.